These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36644799)

  • 1. Structural dynamics and susceptibility of isobutylamido thiazolyl resorcinol (Thiamidol
    Mahalapbutr P; Nuramrum N; Rungrotmongkol T; Kongtaworn N; Sabuakham S
    J Biomol Struct Dyn; 2023; 41(21):11810-11817. PubMed ID: 36644799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
    Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
    J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol).
    Roggenkamp D; Dlova N; Mann T; Batzer J; Riedel J; Kausch M; Zoric I; Kolbe L
    Int J Cosmet Sci; 2021 Jun; 43(3):292-301. PubMed ID: 33559186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole inhibitors of mushroom and human tyrosinases: Current advances and prospects of drug development for melanogenic dermatological disorders.
    Ghani U
    Eur J Med Chem; 2022 Sep; 239():114525. PubMed ID: 35717871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study.
    Philipp-Dormston WG; Vila Echagüe A; Pérez Damonte SH; Riedel J; Filbry A; Warnke K; Lofrano C; Roggenkamp D; Nippel G
    Int J Cosmet Sci; 2020 Aug; 42(4):377-387. PubMed ID: 32390164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety.
    Lee S; Choi H; Park Y; Jung HJ; Ullah S; Choi I; Kang D; Park C; Ryu IY; Jeong Y; Hwang Y; Hong S; Chun P; Moon HR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next Time, Save Mushrooms for the Pizza!
    Hornyak TJ
    J Invest Dermatol; 2018 Jul; 138(7):1470-1472. PubMed ID: 29941098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and inhibition mechanism of some synthetic compounds and phenolic derivatives as tyrosinase inhibitors: review and new insight.
    Vaezi M
    J Biomol Struct Dyn; 2023 Jul; 41(10):4798-4810. PubMed ID: 35510568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase.
    Mann T; Scherner C; Röhm KH; Kolbe L
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Anthocyanins, Deoxyanthocyanins and Pyranoanthocyanins on the Modulation of Tyrosinase Activity: An In Vitro and In Silico Approach.
    Correia P; Oliveira H; Araújo P; Brás NF; Pereira AR; Moreira J; de Freitas V; Mateus N; Oliveira J; Fernandes I
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of 4-amino-2',4'-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells.
    Lazinski LM; Beaumet M; Roulier B; Gay R; Royal G; Maresca M; Haudecoeur R
    Eur J Med Chem; 2024 Feb; 266():116165. PubMed ID: 38262119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells.
    Roulier B; Rush I; Lazinski LM; Pérès B; Olleik H; Royal G; Fishman A; Maresca M; Haudecoeur R
    Eur J Med Chem; 2023 Jan; 246():114972. PubMed ID: 36462443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamidol
    Roggenkamp D; Sammain A; Fürstenau M; Kausch M; Passeron T; Kolbe L
    J Dermatol; 2021 Dec; 48(12):1871-1876. PubMed ID: 34676600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
    Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
    Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
    Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the inhibitory effect of phenol carboxylic acid antioxidants on mushroom tyrosinase by molecular dynamic studies and experimental assessment.
    Shojazadeh T; Zolghadr L; Gharaghani S; JafarKhani S; Molaabasi F; Piri H; Gheibi N
    J Biomol Struct Dyn; 2023; 41(22):13404-13414. PubMed ID: 36856125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for explaining the product inhibition mechanisms via molecular docking: inhibition studies for tyrosinase from
    Kaya ED; Türkhan A; Gür F; Gür B
    J Biomol Struct Dyn; 2022 Oct; 40(17):7926-7939. PubMed ID: 33779508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
    Bagherzadeh K; Shirgahi Talari F; Sharifi A; Ganjali MR; Saboury AA; Amanlou M
    J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
    Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosinase Inhibition and Antimelanogenic Effects of Resorcinol-Containing Compounds.
    Beaumet M; Lazinski LM; Maresca M; Haudecoeur R
    ChemMedChem; 2024 Aug; ():e202400314. PubMed ID: 39105380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.